Related Articles
Expression of the HER-1-4 family of receptor tyrosine kinases in neuroendocrine tumours
Coexpression of the IGF-IR, EGFR and HER-2 is common in colorectal cancer patients
CBX3 predicts an unfavorable prognosis and promotes tumorigenesis in osteosarcoma
Breast cancers with EGFR and HER2 co‑amplification favor distant metastasis and poor clinical outcome
Cytoplasmic ERβ1 expression is associated with survival of patients with Stage IV lung adenocarcinoma and an EGFR mutation at exon 21 L858R subsequent to treatment with EGFR‑TKIs